Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations: a Prospective, Multi-center, Randomized, Parallel Positive Controlled, Non-inferiority Trial
Status: Recruiting
Location: See all (14) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Age 18 to 80 years, any gender;
• Subject is suitable for endovascular treatment of cerebrovascular malformations;
• Subject is able to understand the purpose of the study, shows sufficient compliance with the study protocol and provides a signed informed consent form.
Locations
Other Locations
China
Xuanwu hospital Capital Medical University
RECRUITING
Beijing
The First Hospital of Jilin University
NOT_YET_RECRUITING
Changchun
Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital
RECRUITING
Chengdu
Guangdong Provincial People's Hospital
NOT_YET_RECRUITING
Guangzhou
Nanfang Hospital Southern Medical University
NOT_YET_RECRUITING
Guangzhou
Zhujiang Hospital of Southern Medical University
NOT_YET_RECRUITING
Guangzhou
Anhui Provincial Hospital
NOT_YET_RECRUITING
Hefei
Qilu Hospital of Shandong University
NOT_YET_RECRUITING
Jinan
Jining No.1 People's Hospital
NOT_YET_RECRUITING
Jining
General Hospital of Eastern Theater Command
NOT_YET_RECRUITING
Nanjing
General Hospital of Northern Theater Command
NOT_YET_RECRUITING
Shenyang
Tongji Hospital Tongji Medical College of HUST
NOT_YET_RECRUITING
Wuhan
Henan Provincial People's Hospital
NOT_YET_RECRUITING
Zhengzhou
The First Affiliated Hospital of Zhengzhou University
ACTIVE_NOT_RECRUITING
Zhengzhou
Contact Information
Primary
Jing Pan
jing.pan@ton-bridge.com
18916099975
Backup
Jin Zheng
Time Frame
Start Date: 2024-06-27
Estimated Completion Date: 2026-10
Participants
Target number of participants: 170
Treatments
Experimental: Liquid Embolic System (Tonbridge)
Active_comparator: Onyx Liquid Embolic System (Medtronic)
Related Therapeutic Areas
Sponsors
Leads: Ton-Bridge Medical Tech. Co., Ltd